Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Completed · Phase 2

Conditions studied: Head and Neck Cancer, Precancerous Condition

In brief

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of celecoxib may prevent or treat head and neck cancer. PURPOSE: This randomized phase II trial is studying celecoxib to see how well it works compared to placebo in preventing head and neck cancer in patients with oral leukoplakia.

Key facts

Study ID

NCT00101335

Run by

Fox Chase Cancer Center

Starts

2003-11-01

Expected to finish

2005-01-01

Last updated by the study team

2013-07-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.